Associate Director, Corporate Development
TLDR
Serve as a key strategic partner to the team, driving fundraising, investor relations, board communications, competitive intelligence, and external stakeholder engagement in a fast-paced startup.
Investor Relations & Fundraising Support
Partner with the Vice President, Strategy & Operations, CEO and leadership team to prepare for investor meetings, fundraising processes, and strategic partnering discussions.
Develop and maintain investor-facing materials, including pitch decks, company overviews, diligence responses, and financial and operational updates.
Coordinate investor due diligence activities and manage information requests throughout financing processes.
Build and maintain virtual data rooms, ensuring materials are organized, current, and accessible.
Track fundraising activities, investor engagement, and follow-up actions.
Board & Executive Communications
Coordinate preparation of Board meeting materials, including presentation development, data gathering, and narrative creation.
Partner with functional leaders to synthesize complex scientific and operational information into concise executive-level communications.
Support Board meeting logistics, follow-up actions, and ongoing communication with Board members and observers.
Assist with strategic planning exercises, business reviews, and executive presentations.
Competitive Intelligence & Strategic Analysis
Monitor the kidney disease, ADPKD, and broader nephrology landscape for scientific, clinical, regulatory, and business developments.
Track competitor pipelines, clinical trial activity, financing events, partnerships, and M&A transactions.
Develop competitive intelligence reports and strategic assessments to support executive decision-making.
Analyze emerging technologies, therapeutic modalities, and market trends relevant to Renasant’s portfolio.
Support evaluation of potential partnering, licensing, and business development opportunities.
Scientific & KOL Engagement
Help identify, map, and maintain relationships with key opinion leaders, patient advocacy organizations, and scientific advisors in the ADPKD and nephrology communities.
Support planning and execution of scientific advisory boards, KOL meetings, and major medical conferences.
Capture and synthesize external insights to inform corporate strategy, clinical development planning, and investor communications.
Maintain awareness of evolving standards of care, treatment paradigms, and unmet needs within the ADPKD community.
Cross-Functional Strategic Projects
Support special projects spanning corporate strategy, pipeline prioritization, financing, and business operations.
Collaborate closely with Research, Clinical Development, Regulatory, and Finance teams to gather information and drive execution.
Help establish processes and systems that enable efficient communication with external stakeholders as the company scales.
Required
Bachelor's degree in life sciences, business or related field
8+ years of experience in biotechnology, pharmaceutical, healthcare consulting, investment banking, venture capital, equity research, corporate strategy, or corporate development.
Experience building and managing diligence data rooms.
Strong understanding of drug development and biotechnology financing.
Experience preparing executive-level presentations and synthesizing complex scientific information for diverse audiences.
Exceptional written and verbal communication skills.
Demonstrated ability to manage multiple high-priority projects simultaneously.
Highly organized, detail-oriented, and capable of operating independently in a dynamic startup environment.
Preferred
Advanced degree in a life sciences field (PhD preferred; MBA or additional business training is a plus).
Experience supporting venture financings, Board communications, investor relations, or strategic transactions.
Knowledge of nephrology, rare disease, or ADPKD therapeutic landscapes.
Experience engaging with scientific advisors, key opinion leaders, and patient advocacy organizations.
Please note that we do not accept unsolicited resumes from recruitment agencies and external recruiters. No fees will be paid for such submissions.
Benefits
Equity Compensation
equity participation
Health Insurance
comprehensive health benefits
Performance bonuses
5AM Ventures is a biotechnology firm focused on developing innovative therapies for patients with kidney disease, specifically in the challenging domain of autosomal dominant polycystic kidney disease (ADPKD). The company leverages bold thinking and rigorous scientific approaches to advance solutions that aim to significantly improve patient outcomes.